The Journal of Clinical Endocrinology & Metabolism · 2024 · 10 citations · 29 references
MedicineBiostatisticsOncologyRisk AssessmentSurvival AnalysisTreatment PlanningPatient StratificationResponse AssessmentRisk StratificationTherapy Response AssessmentThyroid CancerClinical Utility AnalysisClinical Utility AssessmentPredictive Model PerformancePredictive PerformancePredictive Performance EvaluationPredictive Risk StratificationPrognostic Factors AnalysisReclassification
BACKGROUND: Various prognostic factors are expected to refine the American Thyroid Association recurrence risk stratification for patients with papillary thyroid cancer (PTC). However, it remains unclear to what extent integrating these factors improves patient treatment decision-making. METHODS: We developed 2 predictive models for structural incomplete response (SIR) at the 1-year follow-up visit, based on comprehensive clinical data from a retrospective cohort of 2539 patients. Model 1 included the recurrence risk stratification and lymph node features (ie, number and ratio of metastatic lymph nodes, N stage). Model 2 further incorporated preablation stimulated thyroglobulin (s-Tg). An independent cohort of 746 patients was used for validation analysis. We assessed the models' predictive performance compared to the recurrence risk stratification using the integrated discrimination improvement (IDI) and the continuous net reclassification improvement (NRI). The clinical utility of the models was evaluated using decision curve analysis. RESULTS: Both model 1 and model 2 outperformed the recurrence risk stratification in predicting SIR, with improved correct classification rates (model 1: IDI = 0.02, event NRI = 42.31%; model 2: IDI = 0.07, event NRI = 53.54%). The decision curves indicated that both models provided greater benefits over the risk stratification system in clinical decision-making. In the validation set, model 2 maintained similar performance while model 1 did not significantly improve correct reclassification. CONCLUSION: The inclusion of lymph node features and s-Tg showed potential to enhance the predictive accuracy and clinical utility of the existing risk stratification system for PTC patients.
29
Discrimination and Calibration of Clinical Prediction Models
Ana Carolina Alba, Thomas Agoritsas, Michael Walsh et al. · JAMA · 2017 · 1.6K citations
Denise Momesso, Fernanda Vaisman, Samantha Peiling Yang et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 230 citations · Full text
Interobserver agreement of various thyroid imaging reporting and data systems
Giorgio Grani, Livia Lamartina, Vito Cantisani et al. · Endocrine Connections · 2017 · 207 citations · Full text